The Kfar Saba-based company received FDA approval for its FFRangio System, a non-invasive device that delivers FFR guidance to optimize PCI therapy decisions.

Two leading Israeli cardiologists talk to "Globes" about the latest technologies in cardiology being developed in the country. "Israel is a world power in innovation - the top in terms of patents per capita, and first in terms of start up companies. In all of Silicon Valley there are 700 start ups. In Israel, there are 1,000 and only 7 million people."